Most material SEC filings — July 2, 2026

MV Oil Trust's net profits interest terminated June 30, 2026, after producing 11.5 MMBoe (the contractual minimum of 14.4 MMBoe total). The Trust dissolved and announced a final distribution of $6,829,206 ($0.593844 per unit) on July 24, 2026 to holders of record July 15. The NYSE will delist the Trust Units prior to market open July 27, 2026, and the Trust will file Form 15 to deregister and cease SEC reporting.

MetaVia Inc. (market cap ~$3.0M) authorized a $4,000,000 at-the-market (ATM) offering of common stock through Ladenburg Thalmann Co. Inc. as sales agent, effective November 6, 2025, with prospectus supplement dated July 2, 2026. The offering is registered under Form S-3 (File No. 333-278646), filed April 12, 2024. This filing is legal counsel's opinion letter confirming the shares will be validly issued, fully paid, and non-assessable when sold.

HeartBeam, Inc. filed Form 8-K on July 2, 2026, reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing indicates the company has failed to maintain exchange listing compliance standards. No specific financial figures, remediation timeline, or detailed reason for the delisting notice are disclosed in the filing header.

AI Financial Corp filed an 8-K on July 2, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The filing itself provides no specifics on which listing standard was violated, the timeline for remediation, or the exchange involved. No dollar amounts, percentages, or quantitative impact details are disclosed in the available document metadata.

On 2026-07-01, Boxlight Corp received notice of failure to satisfy continued listing requirements, triggering a delisting or transfer of listing proceeding per Item 3.01. No specific financial metrics, remediation plan, or timeline details are disclosed in this 8-K. The company (market cap ~$4.5M) faces potential removal from its exchange listing.

Gold Resource Corporation shareholders approved the Arrangement Agreement and Plan of Merger with Goldgroup Mining Inc. (BC) dated January 25, 2026 and amended May 15, 2026, whereby Goldgroup Merger Sub Inc. will merge with GRC, with GRC surviving as a wholly owned subsidiary of Goldgroup. Merger is expected to close on or about July 17, 2026, subject to required approvals and closing conditions. No merger consideration amount or exchange ratio is disclosed in this filing.

FingerMotion, Inc. filed an 8-K on July 2, 2026 disclosing a notice of delisting or failure to satisfy continued listing rules/standards, with potential transfer of listing. The filing provides no specific details on the reason, timeline, remediation plan, or financial impact. Only the existence of the delisting notice and its Item 3.01 classification are disclosed.

SoundHound AI, Inc. agreed to acquire LivePerson, Inc. via merger effective July 2, 2026. LivePerson shareholders will receive Parent Common Stock as consideration (Per Share Merger Consideration amount not specified in this excerpt). The transaction involves two sequential mergers; LivePerson will survive the first merger as an indirect subsidiary of SoundHound, then merge into Merger Sub II. Company capitalization as of April 17, 2026: 12,135,767 common shares outstanding.

Callan JMB Inc. (market cap ~$7.4M) filed an 8-K on July 2, 2026 reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing discloses a delisting notice issued on or about June 29, 2026. No specific details regarding the cause of delisting, timeline to cure deficiencies, or potential remediation actions are provided in the filing excerpt.

Volato Group completed an offering of 11,038,767 shares of Class A common stock pursuant to a Securities Purchase Agreement dated June 27, 2026. The offering was registered via Form S-3 with base prospectus effective September 30, 2025 and prospectus supplement dated June 30, 2026. Legal counsel (Dykema Gossett) opined the shares are duly authorized, validly issued, fully paid and non-assessable. The filing does not specify the price per share or total capital raised.

CNS Pharmaceuticals closed a $22.5 million PIPE financing on May 5, 2026, with participation from ADAR1 Capital, Ikarian Capital, Stonepine Capital Management, and Nazare Partners. The offering consisted of 650,000 common shares at $2.30 and 9,143,479 pre-funded warrants at $2.299. Pro forma fully diluted market cap reaches ~$50.7 million. Concurrent with financing, company pivoted strategy: appointed new CEO (Rami Levin), CFO (Steve O'Loughlin), CTO (Eric Faulkner), CMO (Lynne Kelley), and CBO (Dylan Wenke); exiting legacy GBM pipeline (TPI 287, Berubicin) to pursue high-value oncology/neurology asset acquisitions targeting 12-month value catalysts.

RenovoRx received notice on July 1, 2026, that it has been granted an additional 180-calendar-day compliance period (until December 28, 2026) to regain compliance with Nasdaq's $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)). The company initially received a deficiency notice on December 31, 2025, with a 180-day cure period ending June 30, 2026. If the stock closes at $1.00+ per share for 10 consecutive business days by December 28, 2026, Nasdaq will confirm compliance; otherwise, delisting proceedings commence with potential appeal rights.

On June 29, 2026, TAP Real Estate Technologies, Inc. (Licensee) and TAP, Inc. (Licensor) replaced an original December 30, 2025 license agreement with an Amended and Restated License Agreement granting perpetual, exclusive, irrevocable, royalty-free rights to use TAP's blockchain, wallet, registry, and token-engine technology in the real estate sector globally. Total consideration is $700,000: $695,000 already paid, final $5,000 due by September 30, 2026. The license is exclusive to Licensee in real estate; Licensor retains separate use rights. Perpetual term with no termination except by mutual written amendment.

10% owner Manufacturers Life Reinsurance Ltd (N/A) bought 1.5M shares (~$24.0M) on the open market (3.9% of holdings). Open-market insider purchase — historically a bullish signal.

Lixte Biotechnology Holdings (public market cap ~$2.0M) executed Amendment No. 1 to its merger agreement with NOMAD Transportable Power Systems on June 30, 2026. The amendment modifies treatment of fractional shares: instead of cash payments, fractional shares now round to the nearest whole share (0.5+ rounds up, <0.5 rounds down). Schedule I (stockholder allocations) was updated accordingly. Concurrently, Lixte issued 51,500 shares of Series D Non-Voting Convertible Preferred Stock at $1,000 liquidation value per share (51.5M in preferred stock value), convertible to common stock at 1:1,000 ratio after stockholder approval. Registration rights and support agreements were executed. The merger's economic scale remains unclear without disclosed deal consideration, but the preferred stock issuance alone represents ~2,575% of Lixte's ~$2.0M market cap.

10% owner Uber Technologies, Inc (LIME) bought 11.5M shares (~$20.0M) on the open market (44% of holdings). Open-market insider purchase — historically a bullish signal.

Kartoon Studios (market cap ~$33.8M) adopted comprehensive bylaw amendments on July 1, 2026, substantially restricting stockholder power. Key changes: eliminated stockholder ability to call special meetings or act by written consent; raised quorum to 33.34%; tightened advance notice deadlines for director nominations (120–90 days before meetings); required strict stockholder presence requirements; mandated 66.67% supermajority to amend bylaws; adopted classified board with 2-year staggered terms; and designated Nevada courts as exclusive forum for internal disputes. Company also adopted a form indemnification agreement providing broad director/officer protections, advance expense funding, and Change of Control protections.

Columbus Circle Capital Corp II (a $232.6M SPAC) is merging with Elroy Air, Inc., a Delaware aircraft design/manufacturing company. The merger involves: (1) domestication of the SPAC to Delaware; (2) conversion of Elroy convertible notes into Series A Preferred Stock of the merged entity; (3) issuance of base consideration in Domesticated Purchaser Common Stock plus earnout shares (3-5M per milestone, based on stock price targets of $15-20+); (4) PIPE investment from Series A investors; (5) pre-PIPE convertible note funding. No specific dollar valuations, share counts at closing, or price per share are stated in the filing text.

Pyxis Oncology issued $49,999,990.30 of common stock at $2.551/share and warrants to purchase 19,600,153 shares at $3.289/share to unnamed institutional investors (Wells Fargo Securities as placement agent, dated June 30, 2026, closed July 2, 2026). Warrants exercisable upon MICVO clinical data disclosure or October 1, 2026. Company granted mandatory registration rights with October 2, 2026 filing deadline and 75-day effectiveness requirement, with 1.0% monthly liquidated damages for registration failures.

Algorhythm Holdings exchanged $3.5M of a $10.355M secured pre-paid purchase (PPP #4) held by Streeterville Capital, LLC for 3,500 newly created Series A Preferred Stock shares on June 29, 2026. Each preferred share has a stated value of $1,150, accrues 9% annual return (15% post-default), ranks senior to common stock in liquidation, and carries strict covenants restricting the company's capital structure, asset pledging, and M&A activity. The investor cannot redeem shares; only the company can, at 110% of liquidation value.

On June 30, 2026, Avalon GloboCare sold 400 shares of Series F Convertible Preferred Stock to Allen O. Cage Jr. for $400,000 (stated value $1,000/share). Cage also received 200,000 commitment shares of common stock as additional consideration. The preferred shares are convertible into common stock at $0.50/share (subject to beneficial ownership cap of 4.99%) and subject to mandatory redemption beginning October 1, 2026, with 25% redeemed quarterly at 125% of stated value through January 1, 2027.

On June 30, 2026, Peraso Inc. entered into a Common Stock Purchase Agreement with Roth Principal Investments, LLC, granting Roth the right to purchase up to $25,000,000 of Peraso common stock at the company's sole discretion over 36 months. The agreement permits multiple purchase methods (Market Open, Intraday, Pre-Market, Post-Market) at volume-weighted average prices with fixed discounts (3%–6%). Peraso pays Roth a $500,000 commitment fee (2% of commitment), plus up to $190,000 in legal reimbursements. Up to 31,750,000 shares may be issued, potentially diluting existing shareholders by 67.9% if fully utilized.

Omid Farokhzad, Seer's Chair and CEO, submitted an unsolicited non-binding proposal to acquire all outstanding shares at $2.45/share in cash (41% premium to 30-day VWAP as of June 30, 2026) plus two tiered CVRs: a Revenue-Linked CVR up to $0.25/share tied to 2031 revenue milestones ($50M–$70M+), and a Sale-Linked CVR up to $2.91/share tied to a future sale/strategic transaction within 5 years (tiered from $100M to $1.2B+ Transaction Value). The proposal matches the concurrent Radoff-JEC offer's cash price but adds two separate upside instruments; total potential value is 222% premium if all CVRs pay. Board has established a Special Committee of independent directors with financial advisors (Perella Weinberg) and legal counsel (Wilson Sonsini) to evaluate. Transaction is not subject to financing contingency but requires majority-of-the-minority shareholder approval and customary regulatory clearances.

Cycurion filed Form S-1 on July 2, 2026 to register resale of 25,888,888 common shares: 25,000,000 ELOC Shares issuable to Yield Point NY LLC under an equity purchase agreement dated April 7, 2025, plus 888,888 conversion shares from Series I Convertible Preferred Stock. This is a legal opinion confirming the shares' valid authorization and issuance.

10% owner Endeavor Blockchain, LLC (BGDE) bought 17K shares (~$16.7M) on the open market (50% of holdings). Open-market insider purchase — historically a bullish signal.

AppTech Payments Corp. issued a promissory note to the Suzanne D. Lord Spousal Estate Reduction Trust (Albert L. Lord, Jr., trustee) for $500,000 principal on June 26, 2026. The loan bears 9% annual interest, matures in 90 days (late September 2026), and is unsecured. Proceeds are designated for short-term working capital and general corporate purposes. No principal or interest payments are due before maturity; default triggers include non-payment, bankruptcy, or material breach uncured within 10 business days.

On July 1, 2026, Kartoon Studios' board adopted a Preferred Stock Rights Agreement and designated 300,000 shares of Series D Participating Preferred Stock (par value $0.001/share). Each common shareholder receives one right per share (record date July 13, 2026) to purchase 1/1000th of a Series D preferred share at $3.75 per right. Rights become exercisable upon a 'triggering event': either a 10% ownership stake acquisition ('Acquiring Person') or a tender offer that would create one. Upon such event, non-Acquiring Person rights holders can exercise to purchase common stock at 50% of market price ('flip-in'), while Acquiring Person rights become null and void. Rights expire June 29, 2027, unless earlier redeemed at $0.001/right or exchanged for common stock. VStock Transfer, LLC serves as rights agent.

On 30 June 2026, NIMS extended the maturity dates of four promissory notes by 3 months each—from 30 June 2026 to 30 September 2026. The notes are: (1) $75K to Frost Gamma Investments Trust (Dr. Phillip Frost, director, >10% shareholder), dated 4 Oct 2021; (2) $75K to Dr. Jane Hsiao (Chairman/CEO, >10% shareholder), dated 4 Oct 2021; (3) $75K to Frost Gamma, dated 16 Sept 2022; (4) $75K to Hsiao, dated 16 Sept 2022. Total principal: $300K. No other terms amended. All four amendments were signed 30 June 2026 and filed 2 July 2026. This is the fourth amendment to each note.

Tenax Therapeutics announced its Phase 3 LEVEL clinical trial evaluating TNX-103 (oral levosimendag) for pulmonary hypertension in heart failure with preserved ejection fraction (PH-HFpEF) will present results in a late-breaking session at the European Society of Cardiology Congress on August 29, 2026 in Munich. The trial enrolled >230 patients (completed March 2026); a December 2025 blinded sample size re-estimation confirmed >90% power to detect a 25-meter change in 6-minute walk distance (primary endpoint). Company expects to report topline data in August 2026.

Columbia Financial announced stockholder approval (June 25, 2026) and depositor approval (June 29, 2026) of its second-step conversion from mutual to fully public form and simultaneous acquisition of Northfield Bancorp, Inc. The company received approximately $1.1 billion in subscription offering proceeds (excluding ESOP) through June 30, 2026, and will conduct a firm commitment underwritten offering at $10.00/share for remaining shares. Completion requires minimum sale of 142,375,000 shares and final regulatory approvals including independent appraisal.

CID HoldCo (Dot Ai, ticker DAIC) on June 26, 2026 entered a Note Purchase Agreement with Phillips Equities Trust, LLC for a $500,000 senior secured convertible note at 6% annual interest, maturing 12 months from funding. The note converts at 80% of lowest 5-day VWAP, subject to 4.99%–9.99% beneficial ownership limits. Simultaneously, the company fully retired White Lion Capital's ~$867,000 secured convertible notes and released all associated liens. The Lender also acquired the company's remaining J.J. Astor obligations (first lien priority). On June 23, 2026, Nasdaq confirmed compliance with the $1.00 minimum bid price rule. The company remains non-compliant with MVLS ($50M) and MVPHS ($15M) thresholds.

Avanos Medical and American Industrial Partners announced receipt of all required regulatory approvals for AIP's acquisition of Avanos on July 2, 2026. The transaction is expected to close by July 27, 2026, pending stockholder approval at a special meeting scheduled for July 22, 2026. Specific acquisition price, deal structure, and material terms are not disclosed in this 8-K filing.

For the quarter ended May 31, 2026, EACO Corporation reported net sales of $142.4M (up 27.8% YoY from $111.4M) and net income of $13.6M (up 42.6% from $9.5M); basic EPS rose 43.1% to $2.79. Headcount grew 11% to 491 sales employees; 122 sales focus teams (up 8). Balance sheet shows total assets of $268.1M vs. $230.2M prior year, with retained earnings up to $176.0M. Nine-month net income reached $32.7M on sales of $371.1M.

AJB Investment Fund II LP, AJB Capital LLC, and individuals Adam Bradley and Melinda Bradley collectively acquired 382,016 shares (10.9% of 3.52M outstanding shares) of Jewett Cameron Trading Co Ltd through open market purchases. AJB Fund II owns 300,186 shares purchased for ~$599K; the Bradleys own additional shares purchased for ~$172K combined. The filing was made as of June 30, 2026, with recent purchases on 6/12, 6/22, 6/26, 6/29, 6/30, and 7/1 at prices ranging $1.97–$2.38 per share.

Centrus Energy signed a fixed-price contract with the U.S. Department of Energy for a $900 million task order (total contract value $1.07 billion including options), with $170 million in optional HALEU purchases. The company completed 900 kg of HALEU production ahead of schedule under its prior demonstration contract and intends to transition to commercial-scale production by July 1, 2026, with initial capacity of 12 metric tons annual HALEU production coming online by 2029. A three-month extension valued at $15 million covers interim storage.

JFB Construction Holdings issued 4,400,000 shares of Series C Convertible Preferred Stock (stated value $10/share = $44M), convertible to common at $5.44/share (1.838 shares per preferred share). Simultaneously issued two warrant tranches (Warrant A & B), each for 8,068,933 shares, exercise prices $5.75 and $6.25 respectively, expiring October 1, 2028. Private purchase agreement dated September 26, 2025. Offering intended to recapitalize a Mississippi hotel development project (Courtyard by Marriott, 117 rooms) and fund ongoing construction. Counterparties unnamed in filing.

Navient Corp filed an 8-K on July 2, 2026 disclosing a material cybersecurity incident that occurred on June 29, 2026. The filing lists Item 1.05 (Material Cybersecurity Incidents) but the actual incident details, scope, data affected, remediation steps, financial impact, and number of affected individuals are not provided in this document index—only the filing metadata is shown.

On June 29, 2026, Functional Brands amended Eric Gripentrog's (CEO) executive employment agreement to replace a previously promised $500,000 restricted stock unit award with an immediately fully vested grant of 3,500,000 stock options at $0.0055 exercise price (fair market value on grant date). The options have a 10-year term and Black-Scholes grant-date fair value of approximately $14,685. The Board's Compensation Committee approved this change, which shifts CEO incentive structure from time-based RSUs to options.

South32 Limited agreed to sell its Australian, Brazilian, and South African bauxite/alumina/aluminium operations to Alcoa Corporation for aggregate consideration of approximately $3.1 billion in cash ($3.1B allocated: Australian $1.107B, South African $836M, Brazilian $1.157B) plus Alcoa shares as consideration. The deal includes contingent consideration tied to alumina and aluminium production. Completion is conditional on regulatory approvals, shareholder votes, and financing. Seller (South32) will receive ~57% of consideration shares for Australian/South African assets; Brazilian assets receive no equity consideration, only cash.

On June 30, 2026, iPower Inc. sold $2,007,366.86 of inventory to Global Product Marketing, Inc. in exchange for GPM assuming an equal amount ($2,007,366.86) of iPower's accounts payable to suppliers. The deal also terminated the exclusive distribution and sourcing rights between the parties. iPower retains recourse against GPM if the payables are not paid or inventory remains unsold.

OS Therapies Incorporated signed a Securities Purchase Agreement on June 30, 2026, with Leonite Fund I, LP for a senior secured convertible promissory note with principal amount up to $10,000,000, funded in tranches. The first tranche is $1,600,000 (net $1,565,000 after $35,000 in Leonite's legal fees). The note carries 9% annual interest, 7.5% original issue discount per tranche, converts at $2.05/share, includes 1,750,000 warrant shares at $2.85 exercise price, and 275,000 direct equity shares. The note matures 9 months per tranche (max 24 months from issue). Leonite receives extensive protective covenants, liquidated damages provisions, registration rights, participation/ROFR rights, and holds a first-priority security interest in substantially all company assets excluding intellectual property.

Ernexa Therapeutics Inc. adopted a 2026 Omnibus Equity Incentive Plan on May 6, 2026, subject to shareholder approval. The plan reserves 350,000 common shares for issuance to employees, consultants, and non-employee directors as options, restricted shares, performance shares, and other equity awards. It includes an evergreen provision automatically increasing the reserve by 5% annually (or a lower Board-determined amount) through 2036, subject to adjustment for stock splits and similar events.

Bellevue Capital Partners, LLC purchased 18,000 shares of Class A Common Stock in open market transactions between June 15 and June 30, 2026, at prices ranging from $7.71 to $9.85 per share, for a total cost of approximately $154,000. The largest single purchase was 8,000 shares on June 30, 2026 at $9.53 weighted average price.

Linkhome Holdings completed acquisition of 100% equity interests in Mortgage One Group on July 1, 2026. Mortgage One Group operates $28M warehouse lending capacity, employs 39 professionals, and holds mortgage licenses in 18 U.S. states. Linkhome plans to leverage the platform for new AI Infrastructure Financing business offering GPU server financing and a decentralized GPU Marketplace.

On June 19, 2026, Sintx Technologies issued to MedTech Ceramics, LP: (1) 255,267 released common shares from 507,254 held in abeyance; (2) a pre-funded warrant for 251,987 shares at $0 exercise price (exchanged for remaining abeyance shares); and (3) a new common stock purchase warrant for 1,268,135 shares at $2.14/share (5-year term, replacing MedTech's prior warrant at $4.79/share for 760,881 shares). All securities carry a 9.99% beneficial ownership limit. The company commits to file a resale registration statement within 45 days.

American Rebel Holdings issued a convertible promissory note to 1800 Diagonal Lending LLC on June 23, 2026, with $152,950 principal ($133,000 purchase price, $19,950 original issue discount). The note accrues 18.75% one-time interest, requires 15 monthly payments totaling $181,628, matures September 30, 2027, and converts to common stock at 65% of the 10-day average market price (35% discount) after 180 days or upon default. The agreement includes extensive default provisions, cross-default with other Holder debt, and a 150% default acceleration premium (200% if conversion fails). The company reserved up to $1M in additional tranches over 12 months.

Peraso Inc. entered into a Common Stock Purchase Agreement dated June 30, 2026 with Roth Principal Investments, LLC for up to $25,000,000 in gross proceeds via discretionary share issuances. The company pays a $500,000 commitment fee (via 10% withholding from purchase prices) and $150,000 in investor legal fees ($50,000 upfront + $7,500/quarter capped). Up to 31,750,000 shares (19.99% of outstanding) may be issued, subject to exchange cap and beneficial ownership limits. Roth Capital Partners acts as the investor's broker-dealer for resales under registered offerings.

SoundHound AI (parent) agreed on July 2, 2026 to acquire LivePerson via two-step merger (Merger Sub I merges with LivePerson, then Merger Sub II merges with surviving entity). LivePerson shareholders receive Per Share Merger Consideration in SoundHound common stock plus Per Share Cash Merger Consideration for TASE-listed shares. Agreement amends original April 21, 2026 agreement with revised terms and conditions.

On June 24, 2026, Beeline Financial Holdings (BFH, Beeline's subsidiary) acquired all MagicBlocks shares from selling shareholders for $1.00 total ($0.50 each to two shareholders). Simultaneously, BFH issued up to 215,000 restricted Beeline shares (conversion price ≥$2.25/share) to third-party SAFE holders in exchange for ~$476K in MagicBlocks SAFEs; BFH's own ~$543K SAFEs were cancelled. MagicBlocks' enterprise value was ~$1.01M against ~$1.02M total SAFE obligations, leaving no positive residual equity value. All MagicBlocks options were cancelled without compensation.

On June 29, 2026, Sky Quarry Inc., Foreland Refining Corporation, and 2020 Resources LLC converted $3,985,000 in outstanding merchant cash advance (MCA) obligations owed to Libertas Funding LLC into a single 8% promissory note with a weekly escalating payment schedule (starting at $15,000/week, rising to $70,000/week). Marcus Laun, CEO, personally guaranteed the note. All prior MCA remedies (including acceleration rights, 'Bad Acts' provisions, and ACH debit authorizations) were superseded; Libertas' sole remedy is standard note acceleration on default. Existing security interests under the MCA agreements remain in place and continue to secure the new note.